About Index Trending news
Lists
Pricing
Cytori Therapeutics

Cytori Therapeutics

Cytori Therapeutics

Developing cell therapies for significant medical conditions including hand scleroderma, knee osteoarthritis, thermal burns and stress urinary incontinence.

Elsewhere

Alexa global traffic share

Twitter followers

16 Jun 2016
$17,100,000
Post-IPO equity

Cytori Closes Rights Offering for Gross Proceeds of $17.1 Million | Business Wire

businesswire
+1
08 Oct 2014
$13,500,000
Post-IPO equity
30 May 2014
$10,000,000
Post-IPO equity
01 Jul 2013
$27,000,000
Debt financing